What is SamaCare?
SamaCare operates at the intersection of healthcare technology and pharmaceutical logistics, providing a sophisticated cloud-based workflow automation platform. The company addresses significant friction points in the medical industry, specifically within specialty drug prior authorization, patient enrollment, and benefit verification. By serving a diverse array of stakeholders—including pharmaceutical manufacturers, healthcare providers, and payors—SamaCare facilitates the efficient delivery of life-changing therapies. Its platform is currently deployed across high-acuity medical specialties such as oncology, neurology, rheumatology, and retina care, where administrative efficiency directly correlates with improved patient access and clinical outcomes. Beyond workflow automation, the company offers premium data analytics services that empower pharmaceutical brands to optimize their market access strategies.
How much funding has SamaCare raised?
SamaCare has raised a total of $31.1M across 3 funding rounds:
Unspecified
$2.1M
Series A
$12M
Series B
$17M
Unspecified (2019): $2.1M, investors not publicly disclosed
Series A (2022): $12M led by NextView Ventures, South Park Commons, and Vive Collective
Series B (2024): $17M supported by South Park Commons, Vive Collective, and Questa Capital
Key Investors in SamaCare
South Park Commons
South Park Commons is a community designed for talented technologists, builders, and domain experts who are navigating the transition from prior projects to new ventures, referred to as the -1 to 0 phase.
Vive Collective
Vive Collective is a platform designed to build, fund, and scale digital health companies by providing continuous funding and resources throughout their development journey.
Questa Capital
Questa Capital invests in innovative healthcare companies that aim to enhance patient experiences, reduce costs, and improve overall population health.
What's next for SamaCare?
With this latest strategic investment, SamaCare is well-positioned to accelerate its market penetration and enhance its product suite. The company is expected to leverage this capital to deepen its integration with electronic health record systems and expand its data analytics capabilities, providing pharmaceutical brands with even greater visibility into the patient journey. As the healthcare industry continues to prioritize cost-effective care delivery and administrative simplification, SamaCare's role as a bridge between clinical practice and pharmaceutical access will likely become more pronounced. Future initiatives will likely focus on scaling operations to support a broader range of medical specialties and further automating the complex, manual processes that currently hinder the rapid adoption of specialty therapies.
See full SamaCare company page
